ALTIMMUNE

Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs. The company uses a proprietary technology for non-invasive intranasal delivery, and has shown proof of principle in animals and in initial human clinical studies. Vaxin Inc., formerly known as Vaxin Pharmaceuticals and ImmuneFocus Corporation, was founded in 1997 by Emerging Technology Partners. Early experiments revealed that DNA incorporated into an adenovirus can elicit an immune response when placed on the surface of the skin, and subsequently research was expanded to include applications on the skin in the nose as well as experimentation with other vectors.

#SimilarOrganizations #People #Financial #Event #Website #More

ALTIMMUNE

Social Links:

Facebook

Industry:

Biotechnology Clinical Trials Health Care Test And Measurement

Founded:

1997-01-01

Address:

Gaithersburg, Maryland, United States

Country:

United States

Website Url:

http://www.altimmune.com

Total Employee:

11+

Status:

Active

Contact:

8555571369

Email Addresses:

[email protected]

Total Funding:

51.4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

Current Advisors List

john-nestor_image

John Nestor Scientific Advisor @ Altimmune
Advisor
2019-07-01

Current Employees Featured

m-scot-roberts_image

M. Scot Roberts
M. Scot Roberts Chief Scientific Officer @ Altimmune
Chief Scientific Officer
2012-12-01

not_available_image

Bertrand Georges
Bertrand Georges Chief Technology Officer @ Altimmune
Chief Technology Officer

richard-eisenstadt_image

Richard Eisenstadt
Richard Eisenstadt Chief Financial Officer @ Altimmune
Chief Financial Officer
2021-12-01

not_available_image

Joe Theis
Joe Theis Outside General Counsel @ Altimmune
Outside General Counsel

vipin-garg_image

Vipin Garg
Vipin Garg President and CEO @ Altimmune
President and CEO

william-brown_image

William Brown
William Brown Chief Financial Officer @ Altimmune
Chief Financial Officer
2019-06-01

not_available_image

Vipin Garg
Vipin Garg President and Chief Executive Officer @ Altimmune
President and Chief Executive Officer

m-scott-harris_image

M Scott Harris
M Scott Harris Chief Medical Officer @ Altimmune
Chief Medical Officer
2019-09-01

not_available_image

José Ochoa
José Ochoa Chief Business Officer @ Altimmune
Chief Business Officer

Founder

de-chu-christopher-tang_image

De-chu Christopher Tang

Stock Details

Company's stock symbol is NASDAQ:ALT

Acquisitions List

Date	Company	Article	Price
2019-07-09	Spitfire Pharma	Spitfire Pharma acquired by Altimmune	93 M USD
2017-01-19	PharmAthene	PharmAthene acquired by Altimmune	N/A
2015-02-17	Immune Targeting Systems	Immune Targeting Systems acquired by Altimmune	N/A

Investors List

biomedical-advanced-research-and-development-authority-barda_image

Key Employee Changes

Date	New article
2021-12-13	Altimmune Appoints Richard Eisenstadt as Chief Financial Officer

Official Site Inspections

http://www.altimmune.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.73 K

Host Informations
Whois Informations

Loading ...